Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 85 years old, of any sex
- People who have been admitted to a stroke unit within 72 hours of their stroke symptoms starting
- People whose first-ever stroke has been confirmed by a CT scan or MRI scan, regardless of where in the brain it occurred
- People who have had an initial or repeated TIA (sometimes called a "mini-stroke") — a sudden, brief episode of neurological symptoms thought to be caused by reduced blood flow, lasting less than 24 hours and/or showing no damage on brain imaging
- People who were largely independent in daily life before their stroke (confirm with trial site what this score means for individual circumstances)
- People who are able to give written consent, or whose relative can give consent on their behalf if they are unable to
- People who may be eligible for a specific type of neck artery surgery called carotid endarterectomy (this applies to a smaller part of the study only)
Who may not be able to join:
- Women who are pregnant or breastfeeding
- People who have had a stroke in the past (before this event)
- People who would not be able to follow a rehabilitation program
- People who are already receiving treatment for sleep-disordered breathing (a condition that affects breathing during sleep)
- People who are currently enrolled in another clinical study that has a waiting period before joining a new one
- People who are not part of the French social and health insurance system, or an equivalent system
- People who are in prison or who are under legal protection orders
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Renaud Tamisier, MD, PhD, MBA, University Hospital, Grenoble
Phone: +33 (0)4 76 76 75 40
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Prevalence of Major Adverse Cardiac or Cerebrovascular Events (MACCEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.